Plasma and Tissue Specific miRNA Expression Pattern and Functional Analysis Associated to Colorectal Cancer Patients

Area of Science:

• Molecular Biology
• Oncology
• Genomics

Background:

• MicroRNAs (miRNAs) are increasingly implicated in colorectal cancer (CRC) carcinogenesis and progression.
• The precise molecular mechanisms underlying miRNA involvement in CRC remain unclear.

Purpose of the Study:

• To investigate plasma and tissue miRNA expression profiles in colorectal cancer.
• To identify novel mechanistic insights into CRC development and progression.
• To explore the impact of chemotherapy on plasma miRNA signatures.

Main Methods:

• Agilent microarray technology for plasma miRNA expression profiling.
• Integration with The Cancer Genome Atlas (TCGA) tissue data.
• Quantitative reverse transcription PCR (qRT-PCR) for validation.

Main Results:

• Identified 156 altered miRNAs in colorectal tissue versus normal tissue using TCGA data.
• Detected 359 altered miRNAs in CRC plasma compared to healthy controls.
• Revealed distinct miRNA patterns in chemotherapy-treated versus untreated CRC patients, suggesting roles in drug resistance.

Conclusions:

• Plasma miRNA expression profiles are altered in colorectal cancer and are influenced by chemotherapy.
• Specific miRNAs may serve as potential biomarkers for CRC diagnosis and monitoring.
• Further research is needed to elucidate the mechanisms of miRNA release and function in biofluids.